Monitoring Agency Report for the quarter ended June 30, 2025
INDGN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indegene Limited submitted the Monitoring Agency Report from CARE Ratings for Q1 FY26 (quarter ended June 30, 2025) tracking the use of its Rs. 760 crore IPO proceeds raised in May 2024. Out of the total, Rs. 665.13 crore has been utilized so far, leaving Rs. 94.87 crore unutilized. The debt repayment of subsidiary ISIL Holdings is fully completed at Rs. 395 crore (Rs. 3.67 crore higher than the offer document estimate due to forex differences). General corporate purposes has used Rs. 208.79 crore of the Rs. 230.12 crore allocated, while capex has used Rs. 26.63 crore of the Rs. 102.92 crore planned. The remaining Rs. 94.87 crore is parked in fixed deposits with ICICI Bank (Rs. 93 crore) and monitoring accounts, earning between 6.15% and 6.85% interest. The Monitoring Agency reported no deviation from the stated objects of the issue, though a 35-day delay was noted in the capex object (completed May 5, 2025 vs. the March 31, 2025 target).
This is a routine regulatory disclosure confirming IPO funds are being deployed broadly in line with the stated plan, with no major red flags. The small forex-driven overshoot on debt repayment and the 35-day capex delay are minor; however, investors may want to track whether the remaining Rs. 94.87 crore is deployed in upcoming quarters.